The NF-κB pathway is a critical regulator of inflammation, with its activation in cancer cells leading to cytokine and chemokine secretion that attracts M2 macrophages to the TME, correlating with poor tumor prognosis [69, 70]. The gene discussed is NFKB1; the disease is cancer.